{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:50:46Z","timestamp":1793292646546,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.urology.2021.04.030","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:34:05Z","timestamp":1620434045000},"page":"211-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Post-Surgical Complications After Bladder Outlet Reducing Surgery: An Analysis of The FDA Manufacturer and User Facility Device Experience (MAUDE) Database"],"prefix":"10.1016","volume":"156","author":[{"given":"Jason K.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Santucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran P.","family":"Sajadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti D.","family":"Chouhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2021.04.030_bib0001","first-page":"8802","article-title":"Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study","volume":"24","author":"Roehrborn","year":"2017","journal-title":"Can J Urol"},{"key":"10.1016\/j.urology.2021.04.030_bib0002","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/aja.2012.127","article-title":"Relationship between age and prostate size","volume":"15","author":"Zhang","year":"2013","journal-title":"Asian J Androl"},{"key":"10.1016\/j.urology.2021.04.030_bib0003","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1089\/end.2019.0067","article-title":"Device malfunctions and complications associated with benign prostatic hyperplasia surgery: review of the manufacturer and user facility device experience database","volume":"33","author":"Patel","year":"2019","journal-title":"J Endourol"},{"key":"10.1016\/j.urology.2021.04.030_bib0004","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.juro.2018.02.3088","article-title":"Three-year treatment outcomes of water vapor thermal therapy compared to doxazosin, finasteride and combination drug therapy in men with benign prostatic hyperplasia: cohort data from the MTOPS trial","volume":"200","author":"Gupta","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.04.030_bib0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/1756287218793084","article-title":"Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia","volume":"10","author":"Westwood","year":"2018","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.urology.2021.04.030_bib0006","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.urology.2018.12.041","article-title":"Rez\u016bm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study","volume":"126","author":"McVary","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urology.2021.04.030_bib0007","first-page":"159","article-title":"Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rez\u016bm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"9","author":"Darson","year":"2017","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.urology.2021.04.030_bib0008","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41391-017-0022-9","article-title":"Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience","volume":"21","author":"Mollengarden","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urology.2021.04.030_bib0009","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajur.2017.06.001","article-title":"Update on minimally invasive surgery and benign prostatic hyperplasia","volume":"5","author":"Chung","year":"2018","journal-title":"Asian J Urol"},{"key":"10.1016\/j.urology.2021.04.030_bib0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.urology.2016.05.003","article-title":"Medium-term outcomes of urolift (minimum 12 months follow-up): evidence from a systematic review","volume":"97","author":"Jones","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.urology.2021.04.030_bib0011","series-title":"De Novo Classification Request for Neotract's UroLift System","year":"2013"},{"key":"10.1016\/j.urology.2021.04.030_bib0012","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s40258-015-0218-x","article-title":"The urolift system for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a NICE medical technology guidance","volume":"14","author":"Ray","year":"2016","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.urology.2021.04.030_bib0013","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.juro.2013.05.116","article-title":"The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study","volume":"190","author":"Roehrborn","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.04.030_bib0014","first-page":"192","article-title":"Can the UroLift prostatic implant device treat the symptoms of benign prostatic hypertrophy, avoid sexual dysfunction and reduce hospital TURP waiting times? A single centre, single surgeon experience and review of the literature","volume":"20","author":"Bardoli","year":"2017","journal-title":"Aging Male"},{"issue":"Suppl 3","key":"10.1016\/j.urology.2021.04.030_bib0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bju.13666","article-title":"24-month durability after crossover to the prostatic urethral lift from randomised, blinded sham","volume":"118","author":"Rukstalis","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2021.04.030_bib0016","unstructured":"Data Suggest That Men Should Resolve to Address Their BPH Symptoms in 2019 [press release]. Online: Urolift, January 16, 2019."},{"key":"10.1016\/j.urology.2021.04.030_bib0017","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.juro.2015.10.181","article-title":"Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"195","author":"McVary","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.04.030_bib0018","unstructured":"New Four-Year Data Demonstrate Rezum Water Vapor Therapy Offers Significant Durable Improvement of Benign Prostatic Hyperplasia Symptoms [press release]. Online: Boston Scientific, January 25, 2019."},{"key":"10.1016\/j.urology.2021.04.030_bib0019","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.urology.2015.05.046","article-title":"Efficacy and safety of rez\u016bm system water vapor treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"86","author":"Dixon","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.urology.2021.04.030_bib0020","series-title":"MAUDE - Manufacturer and User Facility Device Experience","year":"2020"},{"key":"10.1016\/j.urology.2021.04.030_bib0021","unstructured":"Administration USFD. Medical Device Reporting (MDR): How to Report Meedical Device Problems.https:\/\/www.fda.gov\/medical-devices\/medical-device-safety\/medical-device-reporting-mdr-how-report-medical-device-problems. [Accessed 31 December 2020]."},{"key":"10.1016\/j.urology.2021.04.030_bib0022","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.juro.2018.05.048","article-title":"Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline","volume":"200","author":"Foster","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.04.030_bib0023","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/end.2016.0396","article-title":"Development of a classification scheme for examining adverse events associated with medical devices, specifically the davinci surgical system as reported in the FDA MAUDE database","volume":"31","author":"Gupta","year":"2017","journal-title":"J Endourol"},{"key":"10.1016\/j.urology.2021.04.030_bib0024","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.urology.2019.11.040","article-title":"Pelvic hematoma following urolift procedure for BPH","volume":"137","author":"Cai","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.urology.2021.04.030_bib0025","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.urology.2019.08.015","article-title":"Pelvic hematoma following urolift procedure for BPH","volume":"133","author":"Pollock","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urology.2021.04.030_bib0026","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.urology.2020.05.006","article-title":"Re: Pelvic hematoma following urolift procedure for BPH,","volume":"142","author":"Gange","year":"2020","journal-title":"Urology"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429521003745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429521003745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:45:46Z","timestamp":1758768346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429521003745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":26,"alternative-id":["S0090429521003745"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2021.04.030","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-Surgical Complications After Bladder Outlet Reducing Surgery: An Analysis of The FDA Manufacturer and User Facility Device Experience (MAUDE) Database","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2021.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}